Guardion Health Sciences

General Information
Business:

 

The Company is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z® that replenishes and restores the macular protective pigment. A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as age-related macular degeneration (“AMD”), computer vision syndrome (“CVS”) and diabetic retinopathy. This risk may be modified by taking Lumega-Z to maintain a healthy macular protective pigment. Additional research has also shown a depleted macular protective pigment to be a biomarker for neurodegenerative diseases such as Alzheimer’s disease and dementia.

 

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 9
Founded: 2009
Contact Information
Address 15150 Avenue of Science, Suite 200, San Diego, California 92128, US
Phone Number 858-605-9055
Web Address http://www.guardionhealth.com
View Prospectus: Guardion Health Sciences
Financial Information
Market Cap $88.7mil
Revenues $0.94 mil (last 12 months)
Net Income $-7.8 mil (last 12 months)
IPO Profile
Symbol GHSI
Exchange NASDAQ
Shares (millions): 1.5
Price range $4.00 - $4.00
Est. $ Volume $6.0 mil
Manager / Joint Managers WallachBeth Capital/ Westpark Capital
CO-Managers -
Expected To Trade: 4/5/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change